Rock Springs Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2M | Sell |
|
|||||
|
2025
Q1 | $27.2M | Sell |
|
|||||
|
2024
Q4 | $26.3M | Buy |
|
|||||
|
2024
Q3 | $26.8M | Sell |
|
|||||
|
2024
Q2 | $25.2M | Sell |
|
|||||
|
2024
Q1 | $32.8M | Buy |
|
|||||
|
2023
Q4 | $25.2M | Sell |
|
|||||
|
2023
Q3 | $71.8M | Sell |
|
|||||
|
2023
Q2 | $72.4M | Buy |
|
|||||
|
2023
Q1 | $55.6M | Buy |
|
|||||
|
2022
Q4 | $76.8M | Buy |
|
|||||
|
2022
Q3 | $46.6M | Buy |
|
|||||
|
2022
Q2 | $6.42M | Buy |
|
|||||
|
2022
Q1 | $9.01M | Buy |
|
|||||
|
2021
Q4 | $12.4M | Buy |
|
|||||
|
2021
Q3 | $12.7M | Buy |
|
|||||
|
2021
Q2 | $13.1M | Buy |
|
|||||
|
2021
Q1 | $15.1M | Buy |
|
|||||
|
2020
Q4 | $13.3M | Buy |
|
|||||
|
2020
Q3 | $13M | Buy |
|
|||||
|
2020
Q2 | $6.05M | Buy |
|
|||||
|
2020
Q1 | $4.77M | Hold |
|
|||||
|
2019
Q4 | $4.99M | Hold |
|
|||||
|
2019
Q3 | $5.12M | Hold |
|
|||||
|
2019
Q2 | $4.31M | Buy |
|